Clinical Trial Update: GALLANT 5 Tesaglitazar Versus Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tesaglitazar with metformin for type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tesaglitazar (tesaglitazar)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED